Not applicableStudy completedNCT02222883What this trial is testingPrevalence of BRCA in Patients With Ovarian CancerWho this might be right forBRCA StatusOvarian Cancer AGO Research GmbH 530
Early research (Phase 1)WithdrawnNCT06681870What this trial is testingASP1893 in Adults With Advanced CLDN6-positive Solid TumorsWho this might be right forCLDN6-positive Solid TumorOvarian CancerEndometrial Cancer+3 more Astellas Pharma Global Development, Inc.
Large-scale testing (Phase 3)UnknownNCT04201561What this trial is testingHigh Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral NeuropathyWho this might be right forChemotherapy-induced Peripheral NeuropathyRecurrent Ovarian CarcinomaOvarian Cancer+2 more Seoul National University Hospital 68
Not applicableStudy completedNCT02096783What this trial is testingScripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic CancerWho this might be right forAnxiety DisorderCervical CancerEndometrial Cancer+8 more University of Wisconsin, Madison 15
Early research (Phase 1)Looking for participantsNCT06646627What this trial is testingClinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian TumorsWho this might be right forOvarian Cancer Stanford University 48
Early research (Phase 1)Study completedNCT00814086What this trial is testingCisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerWho this might be right forChemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more Gynecologic Oncology Group 23
Not applicableUnknownNCT04617470What this trial is testingNiraparib as Maintenance Treatment in Platinum Responsive Ovarian Cancer Patients: a Real Life StudyWho this might be right forOvarian Cancer Fondazione Policlinico Universitario Agostino Gemelli IRCCS 300
Testing effectiveness (Phase 2)UnknownNCT01180504What this trial is testingConsolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian CancerWho this might be right forOvarian CancerTubal CarcinomaPrimary Peritoneal Carcinoma University Hospital Heidelberg 36
Testing effectiveness (Phase 2)Study completedNCT02289950What this trial is testingAssess the Efficacy and Safety of Farletuzumab (MORAb 003) in Combination With Carboplatin Plus Paclitaxel or Carboplatin Plus Pegylated Liposomal Doxorubicin (PLD) in Participants With Low CA125 Platinum-sensitive Ovarian CancerWho this might be right forPlatinum-Sensitive Ovarian Cancer in First Relapse Eisai Inc. 332
Large-scale testing (Phase 3)Temporarily pausedNCT01218490What this trial is testingPelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian CancerWho this might be right forOvarian Cancer Institut Cancerologie de l'Ouest 450
Not applicableStudy completedNCT00419510What this trial is testingGenetic Counseling in African American WomenWho this might be right forBreast CancerOvarian Cancer University of Pennsylvania 204
Very early researchEnded earlyNCT01292733What this trial is testingCancer Screening Program for Women at High Risk for Developing Ovarian CancerWho this might be right forOvarian DiseasesOvarian Neoplasms Swedish Medical Center 534
Large-scale testing (Phase 3)Not Yet RecruitingNCT06188455What this trial is testingMaintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian CancerWho this might be right forOvarian Cancer The First Affiliated Hospital of Xiamen University 37
Not applicableLooking for participantsNCT07070726What this trial is testingUNTOLD Ovarian Cancer Unmet Needs SurveyWho this might be right forOvarian Cancer Masonic Cancer Center, University of Minnesota 2,000
Early research (Phase 1)Ended earlyNCT04315233What this trial is testingRibociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By GenomicsWho this might be right forMetastatic Breast CancerRecurrent Ovarian Carcinoma University of Utah 12
Testing effectiveness (Phase 2)Study completedNCT00022347What this trial is testingTLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00005049What this trial is testingCombination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal CancerWho this might be right forColorectal CancerGastric CancerGastrointestinal Carcinoid Tumor+4 more NYU Langone Health 45
Early research (Phase 1)Study completedNCT00003358What this trial is testingCisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer Memorial Sloan Kettering Cancer Center 24
Not applicableStudy completedNCT05775549What this trial is testingCharacterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian CancerWho this might be right forAdvanced Ovarian Cancer AstraZeneca 24
Testing effectiveness (Phase 2)Ended earlyNCT01392352What this trial is testingHYPAZ: Hypertension Induced by PazopanibWho this might be right forRenal Cell CarcinomaSoft Tissue SarcomaGlioblastoma+8 more Cambridge University Hospitals NHS Foundation Trust 31